Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Therapix Biosciences Ltd ADR TRPXY

Therapix Biosciences Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several innovative immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The operating segments of the group are Development of drugs based on cannabinoid... see more

OTCPK:TRPXY - Post Discussion

Therapix Biosciences Ltd ADR > Short Interest decrease
View:
Post by StuinSea on Dec 30, 2018 8:54am

Short Interest decrease

https://dminute.com/2018/12/29/cohen-lawrence-b-boosted-mastercard-ma-position-by-698412-therapix-biosciences-ltd-american-depositary-sh-trpx-shorts-lowered-by-16-71/
Comment by easyas123 on Dec 30, 2018 4:57pm
I do hope we hear something soon on another option. Any remaining shorters would be scrambling for shares with the low float. The existence of shorts would help to explain our drop to where we are now, that coupled with scared investors.
Comment by edmed on Dec 31, 2018 10:05am
The reason we are where we are now is that the company is almost out of money.....and needs to either get a new loan, arrange financing through a private placement, or bring us a new deal. I am sure the counter offer by FSD was much less than the original 12 dollar offer, but I hope management did not turn down 9 bucks a share hoping to cash in on more in these difficult markets......Israelis can ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities